Comprehensive Transcriptomic Analysis Reveals Cell-Type-Specific Roles of Human Odorant Receptors in Glioblastoma and

Hee Jin Cho1,2, Dong Jun Yeo1,2, HeeWoong Yang3

  • 1Department of Biomedical Convergence Science and Technology, Advanced Institute of Science and Technology, Kyungpook National University, Daegu 41566, Republic of Korea.

Insights

Odorant receptors (ORs) play key roles in glioblastoma (GBM). This study identifies specific ORs in GBM cells, macrophages, and pericytes, revealing their potential as therapeutic targets for this aggressive brain cancer.

Area of Science:

  • Neuroscience
  • Oncology
  • Genomics

Background:

  • Odorant receptors (ORs) are G protein-coupled receptors with emerging roles beyond olfaction.
  • Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options.
  • The function of ORs in GBM remains largely uninvestigated.

Purpose of the Study:

  • To investigate the cell-type-specific roles of ORs in glioblastoma.
  • To identify potential therapeutic targets within the OR family for GBM treatment.

Main Methods:

  • Integrated transcriptomic analysis of GBM patient data.
  • Utilized The Cancer Genome Atlas (TCGA) RNA-seq and single-cell RNA sequencing (scRNA-seq) data.
  • Examined OR expression patterns in tumor cells and the microenvironment.

Main Results:

  • Distinct OR expression patterns were observed across different cell types in GBM.
  • OR51E1 was enriched in pericytes, linked to angiogenesis.
  • OR2B11 correlated with immunosuppressive tumor-associated macrophages.
  • OR2L13 was associated with synaptic activity in recurrent tumors, suggesting roles in treatment adaptation.

Conclusions:

  • ORs exhibit diverse, cell-type-specific functions within the GBM microenvironment.
  • Specific ORs like OR51E1, OR2B11, and OR2L13 are potential therapeutic targets for GBM.
  • Understanding OR roles offers new avenues for GBM progression, immune modulation, and treatment resistance strategies.